BIO REFERENCE LABORATORIES INC Sales Revenue, Services, Other (Deprecated 2018-01-31)
BIO REFERENCE LABORATORIES INC reported Sales Revenue, Services, Other (Deprecated 2018-01-31) of $1.18 billion for the 3-month period ending 2015-04-30, per its 10-Q filed 2015-06-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesGross · last filed 2015-06-09
- BIO REFERENCE LABORATORIES INC sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2015-04-30 was $1.18B, a 15.49% increase year-over-year.
- BIO REFERENCE LABORATORIES INC sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2015-01-31 was $1.07B, a 17.08% increase year-over-year.
- BIO REFERENCE LABORATORIES INC sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2014-10-31 was $1.16B, a 20.72% increase year-over-year.
- BIO REFERENCE LABORATORIES INC sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2014-07-31 was $1.10B, a 21.55% increase year-over-year.
- BIO REFERENCE LABORATORIES INC sales revenue, services, other (deprecated 2018-01-31) for fiscal 2014 was $4.19B, a 18.75% increase from fiscal 2013.
- BIO REFERENCE LABORATORIES INC sales revenue, services, other (deprecated 2018-01-31) for fiscal 2013 was $3.52B, a 15.45% increase from fiscal 2012.
- BIO REFERENCE LABORATORIES INC sales revenue, services, other (deprecated 2018-01-31) for fiscal 2012 was $3.05B, a 22.97% increase from fiscal 2011.
- BIO REFERENCE LABORATORIES INC sales revenue, services, other (deprecated 2018-01-31) for fiscal 2011 was $2.48B, a 30.47% increase from fiscal 2010.
| Period end | Sales Revenue, Services, Other (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Services, Other (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2015-04-30 | $1.18B 10-Q · filed 2015-06-09 | $2.24B 10-Q · filed 2015-06-09 | $3.40B derived: sum of 3 quarters · filed 2015-06-09 | $4.50B derived: sum of 4 quarters · filed 2015-06-09 | |
| 2015-01-31 | $1.07B 10-Q · filed 2015-03-09 | $2.22B derived: sum of 2 quarters · filed 2015-03-09 | $3.32B derived: sum of 3 quarters · filed 2015-03-09 | $4.34B derived: sum of 4 quarters · filed 2015-06-09 | |
| 2014-10-31 | $1.16B derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-13 | $2.26B derived: sum of 2 quarters · filed 2015-01-13 | $3.28B derived: sum of 3 quarters · filed 2015-06-09 | $4.19B 10-K · filed 2015-01-13 | |
| 2014-07-31 | $1.10B 10-Q · filed 2014-09-04 | $2.12B derived: sum of 2 quarters · filed 2015-06-09 | $3.03B 10-Q · filed 2014-09-04 | $3.99B derived: sum of 4 quarters · filed 2015-06-09 | |
| 2014-04-30 | $1.02B 10-Q · filed 2015-06-09 | $1.93B 10-Q · filed 2015-06-09 | $2.89B derived: sum of 3 quarters · filed 2015-06-09 | $3.79B derived: sum of 4 quarters · filed 2015-06-09 | |
| 2014-01-31 | $909.88M 10-Q · filed 2015-03-09 | $1.87B derived: sum of 2 quarters · filed 2015-03-09 | $2.77B derived: sum of 3 quarters · filed 2015-03-09 | $3.64B derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-10-31 | $958.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-13 | $1.86B derived: sum of 2 quarters · filed 2015-01-13 | $2.73B derived: sum of 3 quarters · filed 2015-01-13 | $3.52B 10-K · filed 2015-01-13 | |
| 2013-07-31 | $905.71M 10-Q · filed 2014-09-04 | $1.77B derived: sum of 2 quarters · filed 2014-09-04 | $2.57B 10-Q · filed 2014-09-04 | $3.38B derived: sum of 4 quarters · filed 2015-01-13 | |
| 2013-04-30 | $861.51M 10-Q · filed 2014-06-06 | $1.66B 10-Q · filed 2014-06-06 | $2.47B derived: sum of 3 quarters · filed 2015-01-13 | $3.27B derived: sum of 4 quarters · filed 2015-01-13 | |
| 2013-01-31 | $798.71M 10-Q · filed 2014-03-10 | $1.61B derived: sum of 2 quarters · filed 2015-01-13 | $2.40B derived: sum of 3 quarters · filed 2015-01-13 | $3.17B derived: sum of 4 quarters · filed 2015-01-13 | |
| 2012-10-31 | $814.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-13 | $1.60B derived: sum of 2 quarters · filed 2015-01-13 | $2.37B derived: sum of 3 quarters · filed 2015-01-13 | $3.05B 10-K · filed 2015-01-13 | |
| 2012-07-31 | $790.52M 10-Q · filed 2013-09-06 | $1.55B derived: sum of 2 quarters · filed 2013-09-06 | $2.24B 10-Q · filed 2013-09-06 | $2.24B 10-Q · filed 2012-09-06 | $2.92B derived: sum of 4 quarters · filed 2014-01-13 |
| 2012-04-30 | $763.82M 10-Q · filed 2013-06-07 | $1.45B 10-Q · filed 2013-06-07 | $2.13B derived: sum of 3 quarters · filed 2014-01-13 | $2.78B derived: sum of 4 quarters · filed 2014-01-13 | |
| 2012-01-31 | $683.82M 10-Q · filed 2013-03-11 | $1.36B derived: sum of 2 quarters · filed 2014-01-13 | $2.01B derived: sum of 3 quarters · filed 2014-01-13 | ||
| 2011-10-31 | $677.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-13 | $1.33B derived: sum of 2 quarters · filed 2014-01-13 | $2.48B 10-K · filed 2014-01-13 | ||
| 2011-07-31 | $652.02M 10-Q · filed 2012-09-06 | $1.80B 10-Q · filed 2012-09-06 | |||
| 2010-10-31 | $1.90B 10-K · filed 2013-01-14 |